tradingkey.logo
搜索

Haemonetics Corp

HAE
添加自选
85.540USD
+0.780+0.92%
收盘 07-31 16:00美东报价延迟15分钟
3.87B总市值
41.47市盈率 TTM

关于 Haemonetics Corp 公司

Haemonetics Corporation is a global healthcare company. The Company is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. The Company’s technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. The Company’s Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies, which includes Hemostasis Management, Cell Salvage and Transfusion Management products.

Haemonetics Corp简介

公司代码HAE
公司名称Haemonetics Corp
上市日期Oct 17, 1979
CEOSimon (Christopher A)
员工数量3023
证券类型Ordinary Share
年结日Oct 17
公司地址125 Summer Street
城市BOSTON
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家United States of America
邮编02110
电话17818487100
网址https://www.haemonetics.com
公司代码HAE
上市日期Oct 17, 1979
CEOSimon (Christopher A)

Haemonetics Corp公司高管

名称
名称/职务
职务
持股
持股变动
Ms. Laurie A. Miller
Ms. Laurie A. Miller
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
40.07K
-0.78%
Ms. Michelle L. Basil, J.D.
Ms. Michelle L. Basil, J.D.
Executive Vice President, General Counsel
Executive Vice President, General Counsel
34.51K
+10.58%
Mr. Charles J. Dockendorff, CPA
Mr. Charles J. Dockendorff, CPA
Independent Director
Independent Director
25.04K
--
Mr. Robert E. Abernathy
Mr. Robert E. Abernathy
Independent Director
Independent Director
24.98K
--
Dr. Mark W. Kroll, Ph.D.
Dr. Mark W. Kroll, Ph.D.
Independent Director
Independent Director
23.36K
-5.99%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Chairman of the Board
Independent Chairman of the Board
19.37K
--
Mr. Michael J. Coyle
Mr. Michael J. Coyle
Independent Director
Independent Director
15.39K
--
Ms. Diane M. Bryant
Ms. Diane M. Bryant
Independent Director
Independent Director
7.13K
--
Mr. Roy Galvin
Mr. Roy Galvin
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
7.00K
+53.66%
Mr. Christopher A. Simon
Mr. Christopher A. Simon
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Ms. Laurie A. Miller
Ms. Laurie A. Miller
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
40.07K
-0.78%
Ms. Michelle L. Basil, J.D.
Ms. Michelle L. Basil, J.D.
Executive Vice President, General Counsel
Executive Vice President, General Counsel
34.51K
+10.58%
Mr. Charles J. Dockendorff, CPA
Mr. Charles J. Dockendorff, CPA
Independent Director
Independent Director
25.04K
--
Mr. Robert E. Abernathy
Mr. Robert E. Abernathy
Independent Director
Independent Director
24.98K
--
Dr. Mark W. Kroll, Ph.D.
Dr. Mark W. Kroll, Ph.D.
Independent Director
Independent Director
23.36K
-5.99%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Chairman of the Board
Independent Chairman of the Board
19.37K
--

常见问题

Haemonetics Corp的前五大股东是谁?

Haemonetics Corp 的前五大股东如下:Ms. Laurie A. Miller

有多少机构持有Haemonetics Corp(HAE)的股份?

截至2026Q1,共有737家机构持有Haemonetics Corp的股份,合计持有的股份价值约为58.91M,占公司总股份的126.77%。与2025Q4相比,机构持股有所增加,增幅为664078.00。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有